Abstract
In the era of emerging options for mitral valvular intervention, we sought to characterize the relative utilization, outcomes, and posthospital dispositions of patients referred for transcatheter mitral valve repair (TMVRepair) and surgical mitral valve procedures (SMVP), by cancer-status. Leveraging the National Inpatient Sample, a representative national dataset, ICD-9 codes for all adults >18 years with co-morbid mitral regurgitation, and cancer without metastatic disease admitted from 2003 to 2015 were queried. TMVRepair was performed in 700 hospitalizations from 2012 to 2015, whereas SMVP was utilized during 12,863 hospitalizations from 2003 to 2015. During follow-up, we observed a proportional increase in TMVRepair utilization among cancer patients (vs noncancer), particularly in 2015 (14.2% vs 8.2%, p <0.0001).<0.0001).<0.0001),<0.0001).
PMID: 32171440 [PubMed - as supplied by publisher]
13:30
Photo
Not included, change data exporting settings to download.
256×256, 6.0 KB
13:30
In reply to this message
pubmed: ctoall&ca or conall
Detection of chemotherapy-induced cardiotoxicity with antimyosin pretargeted imaging.
//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--production.springer.de-OnlineResources-Logos-springerlink.gif Related Articles
Detection of chemotherapy-induced cardiotoxicity with antimyosin pretargeted imaging.
J Nucl Cardiol. 2019 08;26(4):1345-1347
Authors: Strauss HW, Mariani G
PMID: 29392625 [PubMed - indexed for MEDLINE]
14:05
Cancer & Heart (Cardio-Oncology, Cardiotoxicity, TEV)
Photo
Not included, change data exporting settings to download.
256×256, 6.0 KB
14:05
In reply to this message
pubmed: caandvteortroorpul
Direct versus conventional anticoagulants for treatment of cancer associated thrombosis: a pooled and interaction analysis between observational studies and randomized clinical trials.
Related Articles
Direct versus conventional anticoagulants for treatment of cancer associated thrombosis: a pooled and interaction analysis between observational studies and randomized clinical trials.
Ann Transl Med. 2020 Feb;8(4):95
Authors: Gu ZC, Yan YD, Yang SY, Shen L, Kong LC, Zhang C, Wei AH, Li Z, Wang XH, Lin HW
No comments:
Post a Comment